(Date:12/3/2009)...ewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, IN...an update on its European commercial launch of MuG... a debilitating side effect of radiation treatment... by Access, partner, SpePharm, in six European cou...Greece and Sweden. Access is conducting pre-market...
(Date:12/3/2009)...3 Peregrine Pharmaceutic... will release its financial results for the second...at 7:00 a.m. EST and will host a conference call a...T on the same day. ,, Peregrine,s senior manage... quarter ended October 31, 2009 and will review re...
(Date:12/3/2009)...dia, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, ...ke Biotechnology Co. Ltd.,( http://www.beikebiotec...tic,Foot Care in New Delhi, India, November 22, 20...d regenerative medicine company. , The co...tion (IPA), aimed,to help podiatrists and research...
(Date:12/2/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Neurostimulation - A Global Market Pe...4232/Neurostimulation---A-Global-Market-Perspectiv...tands enthused by the growing base of aging popula...es such as, Parkinson,s, and Alzheimer,s disease. ...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6...Probe,s Commercial Expansion in, Fast-Growing Euro...ies and Markers -, ...t Standalone Molecular, Diagnostics Company, Provi... Diverse Customer Needs Around the Worl...asdaq: GPRO ), a pioneer and leader in nucleic ac...
...fted to maneuver separately without any obvious gu...ctures after years of continuing research led by a...elous to be able to do assembly and control at thi...gs," said Bruce Donald, a Duke professor of comput... shaped something like a spatula but with dimensio...
..., June 3, 2008, TIME: 9:30 a.m. Eastern Tim...EO Kendle (Nasdaq: KNDL ) will conduct a telepho...sday, June 3 at 9:30 a.m. Eastern Time to,discuss ...Corporation that,was announced on May 30 and to pr...tion and answer session will follow., (Logo: htt...
Other Biology Technology:Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 2Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 3Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 4Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 5Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 6Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 7Microrobots dance on something smaller than a pin's head 2Microrobots dance on something smaller than a pin's head 3Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress 2Scaffold Software from Proteome Software Inc.
Normal Goat Serum from Calbiochem
TRIzol LS Reagent from Invitrogen
UltraPure DNase/RNase-Free Distilled Water from Invitrogen
Biology Products: